Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
13.68
+0.22 (+1.63%)
Range 13.28 - 13.68
Open 13.42
Prev Close 13.46
52 Week 6.91 - 15.79
Volume 437425
Market Cap 1.42B
*Delayed 5/27/2016 4:00 EDT

 
Form 8937 for 2015 Reverse Stock Split

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000